language_icon
EN
HI

Nath Bio-Genes (India) Share price

NATHBIOGEN

167.2

3.86 (2.36%)
NSE
BSE
Last updated on 13 May, 2026 | 12:02 IST
Today's High

173.29

Today's Low

162.02

52 Week Low

126.15

52 Week High

238.69

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Nath Bio-Genes (India) Chart

Nath Bio-Genes (India) Share Key Metrics

Volume
62463.00
Market Cap
310.41 CR
LTQ@LTP
10@167.20
ATP
168.56
Var Margin
19.91 %
Circuit Range
130.68-196
Delivery %
27.9 %
Value
1.05 CR
ASM/GSM
No
Market Lot
1

Summary

Nath Bio-Genes (India) share price stands at ₹167.2 at 13 May, 2026 | 12:02. The stock Nath Bio-Genes (India) intraday movement has stayed between ₹162.02 and ₹173.29, while on a 52-week basis it has fluctuated from ₹126.15 to ₹238.69.
In terms of trading activity, Nath Bio-Genes (India) has recorded a volume of 62463 shares. The Nath Bio-Genes (India) has a market cap of ₹19004000. The stock’s Average Traded Price (ATP) stands at ₹16856, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10, 16720.
The Nath Bio-Genes (India) operates within a circuit range of ₹130.68-196 – ₹130.68-196, with a Value of ₹1.05 CR. The Delivery Percentage for the day is 27.9%. Additionally, Nath Bio-Genes (India) currently falls under the No framework, and trades with a market lot size of 1.

Nath Bio-Genes (India) Fundamentals

View More
P/E Ratio

7.81

P/B Ratio

0.48

Div. Yield

1.17

Sector P/E

33.92

Sector P/B

1.4

Sec. Div. Yield

0.37

Nath Bio-Genes (India) Resistance and Support

Pivot 165.78

Resistance

First Resistance

169.56

Second Resistance

175.78

Third Resistance

179.56

Support

First Support

159.56

Second Support

155.78

Third Support

149.56

Nath Bio-Genes (India) Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

45.6%

Mutual Fund

0.01%

Insurance

0%

Foreign Institutional Investors

0.22%

Domestic Institutional Investors

0.01%

Retail

54.17%

Others

-0.01%

Total Promoters
MAR '26
45.6%

Nath Bio-Genes (India) Corporate Actions

DateAgenda
2026-05-04Audited Results & Final Dividend
2026-01-31Quarterly Results
2025-11-13Quarterly Results
2025-04-29Audited Results & Final Dividend
2025-01-23Quarterly Results

Nath Bio-Genes (India) News

Nath Bio-Genes (India) Ltd - 537291 - NBIL Concall

Nath Bio-Genes informed that the audio recording of the conference call held on May 5, 2026, is available on its website. The call discussed the audited financial results for Q4 FY26 and year ended March 31, 2026.
May 11 2026 16:05:00

Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Outcome for Outcome Of Board Meeting

Nath Bio-Genes reported strong FY26 cons. results: revenue climbed 22% to ₹445.10 crore, and net profit increased 8% to ₹41.63 crore. The board recommended a final dividend of ₹2 per share and approved the reappointment of Mr. Hitesh Rajnikant Purohit as Independent Director for a second 5-year term.
May 04 2026 17:05:00

Nath Bio-Genes (India) Limited

Nath Bio-Genes board to meet on May 4, 2026, to approve audited financial results for Q4 and FY26. The meeting will also consider a dividend recommendation for 2025-26, subject to shareholder approval.
Apr 25 2026 20:04:00

Nath Bio-Genes (India) Limited

Nath Bio-Genes board to meet on May 4, 2026, to consider and approve audited quarterly financial results for Q4 FY26 and recommend a final dividend. The results will be both standalone and cons. The dividend recommendation is subject to shareholder approval.
Apr 25 2026 20:04:00

Nath Bio-Genes (India) Limited

Nath Bio-Genes (India) Limited disclosed that 13.78% of its promoter and promoter group shares are pledged. This amounts to 6.28% of the company's total shares as of March 31, 2026, raising concerns about promoter liquidity or the company's financial health.
Apr 21 2026 11:04:00
Read More

About Nath Bio-Genes (India)

NSE : 11065  
BSE : 537291  
ISIN : INE448G01010  

Nath Bio-Genes (India) Management

NamePosition
Satish KagliwalManaging Director
Jeevanlata KagliwalExecutive Director
View More

Nath Bio-Genes (India) FAQs

The Buying Price of Nath Bio-Genes (India) share is 167.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Nath Bio-Genes (India) stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Nath Bio-Genes (India), choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Nath Bio-Genes (India) shares is 7.81. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Nath Bio-Genes (India) shares is 0.48. Useful to assess the stock's value relative to its book value.

To assess Nath Bio-Genes (India)’s valuation compare Sector P/E, P/B which are 33.92 & 1.4 with sector averages, along with growth rates and financial metrics.

The Market Cap of Nath Bio-Genes (India) is 310.41 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Nath Bio-Genes (India) share price is 238.69 & 126.15. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Nath Bio-Genes (India) belongs to the Agriculture sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost